If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksThames V.2 Dp67 Regulatory News (D467)

  • This share is currently suspended. It was suspended at a price of 24.00
  • There is currently no data for D467

Net Asset Values and Portfolio Updates

3 Aug 2021 18:49

Net Asset Values and Portfolio Updates

Downing FOUR VCT plc (the β€œCompany”)LEI: 21380035MV1VRYEXPR95 Net Asset Values and Portfolio Updates3 August 2021

The Company announces that the unaudited Net Asset Values (β€œNAVs”) of its Share Classes, as at 31 July 2021, were as follows:

Β Unaudited
Β 31 July 2021
Β Pence
Generalist Share poolΒ 
Net Asset Value (β€œNAV”) per Generalist Share66.5
Cumulative distributions2.5
Total Return per Generalist Share69.0
Β Β 
Healthcare Share poolΒ 
Net Asset Value (β€œNAV”) per Healthcare Share81.5
Cumulative distributions2.5
Total Return per Healthcare Share84.0
Β Β 
DSO D Share poolΒ 
Net Asset Value (β€œNAV”) per DSO D Share10.0
Cumulative distributions94.5
Adjusted for Performance Incentive estimate(0.4)
Total Return per DSO D Share104.1
Β Β 
DP67 Share poolΒ 
Net Asset Value (β€œNAV”) per DP67 Share19.5
Cumulative distributions (since original launch)67.8
Total Return per DP67 Share87.3

The unaudited Balance Sheet of the Company is shown below, followed by a summary of the portfolio of investments held by each Share Class.

UNAUDITED BALANCE SHEET as at 31 July 2021

Β Unaudited31 July 2021Β Β Audited31 March 2021
 £’000 £’000
Fixed assetsΒ Β Β Β 
InvestmentsΒ 44,016Β 40,743
Current assetsΒ Β Β Β 
DebtorsΒ 406Β 701
Cash at bank and in handΒ 6,970Β 6,986
Β Β 7,376Β 7,687
Creditors: amounts falling due within one yearΒ (457)Β (381)
Net current assets6,919Β 7,306
Net assetsΒ 50,935Β 48,049
Β Β Β Β Β 
Capital and reservesΒ Β Β Β 
Called up Share capital Β 102Β 102
Other reservesΒ 58Β 58
Special reserveΒ 29,111Β 29,417
Share premium accountΒ 20,493Β 20,010
Funds held in respect of shares not yet allottedΒ 346Β 241
Revaluation reserveΒ 1,681Β (1,143)
Capital reserve – realisedΒ 3,165Β 3,132
Revenue reserveΒ (4,021)Β (3,768)
Total equity Shareholders’ fundsΒ 50,935Β 48,049
Β Β Β Β 

PORTFOLIO SUMMARIES

as at 31 July 2021

Generalist Share PoolΒ CostΒ Valuation% ofnet assets
Portfolio of investments (unaudited) £’000  £’000 Β 
Venture Capital investmentsΒ Β Β 
E-Fundamentals (Group) LimitedΒ 1,342 Β 2,760 8.64%
Imagen LimitedΒ 1,000 Β 2,020 6.33%
Virtual Class Limited (Third Space Learning)Β 1,053 Β 1,833 5.74%
Rated People LimitedΒ 1,282 Β 1,583 4.95%
Cornelis Networks, Inc.Β 1,402 Β 1,294 4.05%
Streethub Limited (t/a Trouva)Β 1,208 Β 1,273 3.98%
Firefly Learning LimitedΒ 1,047 Β 1,047 3.28%
Ecstase Limited (t/a ADAY)Β 1,000 Β 1,000 3.13%
Trinny London LimitedΒ 219 Β 957 2.99%
Limitless Technology LimitedΒ 757 Β 920 2.88%
FundingXchange LimitedΒ 1,050 Β 786 2.46%
Hackajob LimitedΒ 784 Β 784 2.45%
Congenica LimitedΒ 734 Β 746 2.33%
Arecor Therapeutics plc^^Β 418 Β 743 2.32%
Ayar Labs, Inc.Β 764 Β 720 2.25%
Parsable, Inc.Β 766 Β 672 2.10%
Masters of Pie LimitedΒ 667 Β 667 2.09%
Carbice CorporationΒ 656 Β 603 1.89%
Hummingbird Technologies LimitedΒ 750 Β 535 1.67%
JRNI LimitedΒ 525 Β 525 1.64%
Maverick Pubs (Holdings) LimitedΒ 1,000 Β 450 1.41%
Fenkle Street LLPΒ 301 Β 388 1.21%
Cambridge Touch Technologies LimitedΒ 459 Β 361 1.13%
Exonar LimitedΒ 550 Β 358 1.12%
Destiny Pharma plc^^Β 500 Β 354 1.11%
Xupes LimitedΒ 933 Β 291 0.91%
Channel Mum LimitedΒ 675 Β 278 0.87%
Empiribox Holdings LimitedΒ 1,563 Β 262 0.82%
FVRVS Limited (t/a Fundamental VR)Β 250 Β 250 0.78%
Upp Technologies Group Limited (prev. Volo Commerce)Β 1,077 Β 242 0.76%
Lineten LimitedΒ 400 Β 209 0.65%
MIP Diagnostics LimitedΒ 200 Β 200 0.63%
Lignia Wood Company LimitedΒ 1,778 Β - 0.00%
Live Better With LimitedΒ 1,211 Β - 0.00%
Ormsborough LimitedΒ 900 Β - 0.00%
Glownet LimitedΒ 741 Β - 0.00%
Β 29,962Β 25,111 78.57%
Liquidity investmentsΒ Β Β 
Downing Strategic Micro-Cap Investment Trust plc^Β 4,269 Β 3,050 9.54%
MI Downing UK Micro-Cap Growth FundΒ 124 Β 99 0.31%
Β Β 4,393 Β 3,149 9.85%
Β 34,35528,26088.42%
Cash at bank and in handΒ 3,77311.80%
Other current assetsΒ (71)(0.22%)
Net assets Β 31,962 100.0%

^ listed and traded on the London Stock Exchange^^ listed and traded on AIM

Healthcare Share Pool Β CostΒ Valuation% ofnet assets
Portfolio of investments (unaudited) £’000  £’000 Β 
Venture Capital investmentsΒ Β Β 
Arecor Therapeutics plc^^Β 1,533 Β 2,726 17.04%
GENinCode plc^^Β 1,202 Β 2,165 13.53%
Adaptix LimitedΒ 1,056 Β 1,381 8.63%
Open Bionics LimitedΒ 1,000 Β 1,379 8.61%
Congenica LimitedΒ 1,184 Β 1,215 7.59%
Future Health Works Limited (t/a MyRecovery) Β 528 Β 556 3.48%
The Electrospinning Company LimitedΒ 478 Β 544 3.40%
Destiny Pharma plc^^Β 750 Β 530 3.31%
FVRVS Limited (t/a Fundamental VR)Β 500 Β 500 3.13%
Invizius LimitedΒ 500 Β 500 3.13%
DiA Imaging Analysis LimitedΒ 415 Β 405 2.53%
Cambridge Respiratory Innovations LimitedΒ 400 Β 400 2.50%
MIP Diagnostics LimitedΒ 200 Β 200 1.25%
Live Better With LimitedΒ 1,106 -0.00%
Β 10,85212,501 78.13%
Liquidity InvestmentsΒ Β Β 
Downing Strategic Micro-Cap Investment Trust plc^Β 729 Β 520 3.25%
MI Downing UK Micro-Cap Growth FundΒ 40 Β 32 0.20%
Β Β 769 Β 552 3.45%
Β 11,62113,05381.58%
Cash at bank and in handΒ 2,87217.95%
Other current assetsΒ 750.47%
Net assets Β 16,000100.0%

^ listed and traded on the London Stock Exchange^^ listed and traded on AIM

DSO D Share poolΒ CostValuation% ofnet assets
Portfolio of investments (unaudited) £’000  £’000 Β 
Venture Capital investmentsΒ Β Β 
Fresh Green Power LimitedΒ 189 Β 279 35.36%
Pearce and Saunders LimitedΒ 275 Β 76 9.63%
Green Energy Production UK LimitedΒ 100 Β 66 8.37%
Pearce and Saunders DevCo LimitedΒ 19 Β 19 2.41%
Β Β 583 Β 440 55.77%
Cash at bank and in handΒ Β 315 39.92%
Other current assetsΒ Β 34 4.31%
Net assets Β 789100.00%

DP67 Share poolΒ CostValuation% ofnet assets
Portfolio of investments (unaudited) £’000  £’000 Β 
Venture Capital investmentsΒ Β Β 
Cadbury House Holdings LimitedΒ 1,409 Β 791 36.22%
Gatewales LimitedΒ 343 Β 745 34.11%
Fenkle Street LLPΒ 405 Β 727 33.29%
Yamuna Renewables LimitedΒ 400 Β - 0.00%
London City Shopping Centre LimitedΒ 99 Β - 0.00%
Β Β 2,656 Β 2,263 103.62%
Cash at bank and in handΒ 10 0.46%
Other current assetsΒ (89)(4.08%)
Net assets Β 2,184100.00%

Date   Source Headline
15th Nov 20244:05 pmGNWResults of General Meeting, Merger and Share Redesignation
15th Nov 20241:38 pmGNWNet Asset Value(s)
15th Nov 20247:00 amGNWSuspension of Listing
8th Nov 20245:00 pmGNWResult of General Meeting
11th Oct 20243:02 pmGNWProposed Merger and Offer
25th Sep 202412:21 pmGNWNet Asset Values
24th Sep 20244:40 pmGNWResults of AGM
24th Sep 20242:49 pmGNWInvestment Management Update
7th Aug 20244:30 pmGNWCorrection - Annual Financial Report
31st Jul 20243:40 pmGNWAnnual Financial Report
26th Jul 20244:32 pmGNWAnnouncement re: DISCUSSIONS REGARDING POSSIBLE COMBINATION OF THAMES VENTURES VCT 1 PLC AND THAMES VENTURES VCT 2 PLC
17th Jul 20249:21 amGNWPDMR Notification
28th Mar 20241:15 pmGNWCancellation of Listing of DSO D Shares and Cessation of Trading
15th Mar 202410:21 amGNWNet Asset Value(s)
29th Feb 20244:58 pmGNWDividend Declaration
21st Dec 20233:34 pmGNWHalf Yearly Results
18th Oct 20234:33 pmGNWSpecial administration of the Company’s custodian of quoted assets
13th Sep 20235:14 pmGNWNet Asset Values
13th Sep 20235:06 pmGNWCompany Secretary Change
13th Sep 20235:03 pmGNWResult of AGM
31st Jul 20233:57 pmGNWClosure of Offers for Subscription
31st Jul 20233:14 pmGNWFinal Results
31st May 20235:28 pmGNWTotal Voting Rights
30th May 20232:12 pmGNWOffer for Subscription Extension
12th May 20231:42 pmGNWIssue of Equity
2nd May 202310:49 amGNWTotal Voting Rights
5th Apr 20236:24 pmGNWIssue of Equity
31st Mar 20236:04 pmGNWTotal Voting Rights
31st Mar 20235:44 pmGNWTransaction in Own Shares
22nd Mar 20234:14 pmGNWNet Asset Values
31st Jan 20235:45 pmGNWTotal Voting Rights
17th Jan 20234:57 pmGNWTransaction in Own Shares & Total Voting Rights
22nd Dec 20225:08 pmGNWHalf-year report
13th Oct 20225:35 pmGNWPublication of Healthcare Prospectus
12th Oct 20224:40 pmGNWPortfolio Update and Net Asset Values
30th Sep 20225:27 pmGNWTotal Voting Rights
30th Sep 20225:25 pmGNWTransaction in Own Shares
28th Sep 20223:19 pmGNWDirectorate change
27th Sep 20225:56 pmGNWResult of AGM
7th Sep 202212:00 pmGNWChange of Name
1st Sep 202210:05 amGNWTotal Voting Rights
31st Aug 20224:59 pmGNWShare forfeiture and cancellation
3rd Aug 20225:12 pmGNWTransaction in Own Shares and Total Voting Rights
26th Jul 20227:00 amGNWNet Asset Value(s)
25th Jul 20226:28 pmGNWFinal Results
5th Jul 20227:00 amGNWCompletion of Sale of Downing non-healthcare ventures business to Foresight Group and Novation of Investment Management Agreement
30th Jun 20226:30 pmGNWTotal Voting Rights
13th Jun 20227:04 amGNWNovation of Investment Management Agreement
6th Jun 20224:34 pmGNWIssue of Equity
3rd May 202210:38 amGNWTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.